Literature DB >> 33285390

Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder.

Caroline V Ott1, Ulla Knorr1, Andreas Jespersen1, Kia Obenhausen1, Isabella Røen1, Scot E Purdon2, Lars V Kessing3, Kamilla W Miskowiak4.   

Abstract

BACKGROUND: The International Society for Bipolar Disorders Targeting Cognition Task Force recommends screening for and monitoring of cognitive impairments in patients with bipolar disorder (BD) with the Screen for Cognitive Impairment in Psychiatry (SCIP). The study aimed to provide the first demographically adjusted norms and change norms for the SCIP and to compare the cognitive trajectory over one year in remitted BD patients with normative cognitive change.
METHODS: Patients with fully or partially remitted BD and healthy controls (HC) were assessed with the SCIP at baseline and at a one-year follow-up. Regression-based models were used to determine demographically adjusted norms and change norms. Using the change models, predicted follow-up scores were calculated for BD and HC, and independent t-tests were used to compare deviations of the observed from the predicted follow-up scores for BD vs. HC to assess differences in cognitive trajectories.
RESULTS: Baseline data were collected for n=273 HC and n=218 BD, and follow-up data for n=139 HC and n=74 BD. Baseline norm models included age, sex and years of education, while change models included baseline SCIP scores and age. Patients with follow-up data showed selective impairments within verbal learning and recall at baseline. They followed the normative cognitive trajectories for all cognitive domains but verbal learning. LIMITATIONS: Cognition was assessed with a screening tool.
CONCLUSIONS: We recommend implementing demographically adjusted norms and change norms for the SCIP in clinical and research settings. Change norms seem sensitive to subtle and selective cognitive decline over one year in remitted BD.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Cognition; bipolar disorder; neuropsychological tests

Year:  2020        PMID: 33285390     DOI: 10.1016/j.jad.2020.11.119

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications.

Authors:  K W Miskowiak; L Fugledalen; A E Jespersen; S M Sattler; D Podlekareva; J Rungby; C M Porsberg; S Johnsen
Journal:  Eur Neuropsychopharmacol       Date:  2022-04-14       Impact factor: 5.415

Review 2.  Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence.

Authors:  Wenyu Dai; Jieyu Liu; Yan Qiu; Ziwei Teng; Sujuan Li; Hui Yuan; Jing Huang; Hui Xiang; Hui Tang; Bolun Wang; Jindong Chen; Haishan Wu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

3.  Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G).

Authors:  Gabriele Sachs; Iris Lasser; Scot E Purdon; Andreas Erfurth
Journal:  Schizophr Res Cogn       Date:  2021-05-12

4.  Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables.

Authors:  K W Miskowiak; S Johnsen; S M Sattler; S Nielsen; K Kunalan; J Rungby; T Lapperre; C M Porsberg
Journal:  Eur Neuropsychopharmacol       Date:  2021-03-29       Impact factor: 4.600

5.  Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools.

Authors:  Johan Høy Jensen; Kamilla Woznica Miskowiak; Scot E Purdon; Jane Frølund Thomsen; Nanna Hurwitz Eller
Journal:  Scand J Work Environ Health       Date:  2021-09-28       Impact factor: 5.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.